According to BridgeBio Pharma
's latest financial reports the company's current revenue (TTM ) is โฌ0.20 Billion. an increase over the revenue in the year 2023 that were of โฌ8.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โฌ0.21 B | 2433.91% |
2023 | โฌ8.41 M | -88.37% |
2022 | โฌ72.38 M | 17.59% |
2021 | โฌ61.55 M | 817.9% |
2020 | โฌ6.7 M | -81.48% |
2019 | โฌ36.2 M | |
2018 | N/A |